Overview of the trastuzumab (Herceptin) anti-HER2 monoclonal antibody clinical program in HER2-overexpressing metastatic breast cancer

Authors
Shak, S
Citation
S. Shak, Overview of the trastuzumab (Herceptin) anti-HER2 monoclonal antibody clinical program in HER2-overexpressing metastatic breast cancer, SEMIN ONCOL, 26(4), 1999, pp. 71-77
Citations number
21
Categorie Soggetti
Oncology,"Onconogenesis & Cancer Research
Journal title
SEMINARS IN ONCOLOGY
ISSN journal
00937754 → ACNP
Volume
26
Issue
4
Year of publication
1999
Supplement
12
Pages
71 - 77
Database
ISI
SICI code
0093-7754(199908)26:4<71:OOTT(A>2.0.ZU;2-7